PITTSBURGH & LONDON--(BUSINESS WIRE)--Helomics™ Corporation, a privately-held personalized healthcare company that provides comprehensive tumor profiling products and services based on both live and fixed cell assays, announced today a groundbreaking partnership with Genomics England as part of the inaugural group of industry collaborators to join the 100,000 Genomes Project. Helomics will serve as a founding member and the sole diagnostics-focused company represented in the Genomics Expert Net
| < Prev | Next > |
|---|
